1. Home
  2. NLSP vs AIRI Comparison

NLSP vs AIRI Comparison

Compare NLSP & AIRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • AIRI
  • Stock Information
  • Founded
  • NLSP 2015
  • AIRI 1979
  • Country
  • NLSP Switzerland
  • AIRI United States
  • Employees
  • NLSP N/A
  • AIRI N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • AIRI Military/Government/Technical
  • Sector
  • NLSP Health Care
  • AIRI Industrials
  • Exchange
  • NLSP Nasdaq
  • AIRI Nasdaq
  • Market Cap
  • NLSP 12.4M
  • AIRI 13.4M
  • IPO Year
  • NLSP 2021
  • AIRI N/A
  • Fundamental
  • Price
  • NLSP $2.13
  • AIRI $3.52
  • Analyst Decision
  • NLSP
  • AIRI
  • Analyst Count
  • NLSP 0
  • AIRI 0
  • Target Price
  • NLSP N/A
  • AIRI N/A
  • AVG Volume (30 Days)
  • NLSP 268.4K
  • AIRI 1.5M
  • Earning Date
  • NLSP 07-22-2025
  • AIRI 08-13-2025
  • Dividend Yield
  • NLSP N/A
  • AIRI N/A
  • EPS Growth
  • NLSP N/A
  • AIRI N/A
  • EPS
  • NLSP N/A
  • AIRI N/A
  • Revenue
  • NLSP N/A
  • AIRI $53,182,000.00
  • Revenue This Year
  • NLSP N/A
  • AIRI $5.59
  • Revenue Next Year
  • NLSP N/A
  • AIRI $5.00
  • P/E Ratio
  • NLSP N/A
  • AIRI N/A
  • Revenue Growth
  • NLSP N/A
  • AIRI 0.29
  • 52 Week Low
  • NLSP $1.30
  • AIRI $3.00
  • 52 Week High
  • NLSP $15.59
  • AIRI $9.44
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 43.58
  • AIRI 54.02
  • Support Level
  • NLSP $2.20
  • AIRI $3.35
  • Resistance Level
  • NLSP $2.33
  • AIRI $4.17
  • Average True Range (ATR)
  • NLSP 0.25
  • AIRI 0.17
  • MACD
  • NLSP -0.07
  • AIRI 0.03
  • Stochastic Oscillator
  • NLSP 6.86
  • AIRI 30.11

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About AIRI Air Industries Group

Air Industries Group is an aerospace and defense company. Its manufactures and designs structural parts and assemblies that focus on flight safety, including landing gear, arresting gear, engine mounts, flight controls, throttle quadrants, jet engines, and other components. The company also provides sheet metal fabrication of aerostructures, tube bending, and welding services.

Share on Social Networks: